Company intelligence / Profile preview

Hainan Changan International Pharmaceutical Co., Ltd.

Ownership: Private
Development stage: Commercial

Overview

Hainan Changan International Pharmaceutical Co., Ltd. operates as a pharmaceutical manufacturing company based in Haikou, Hainan, China. Detailed information about its clinical results or product pipeline was not found in the provided sources[2][4].

Industry: Contract Manufacturing Organization

Drug pipeline

1 asset

lobaplatin

Commercial

Indications: Advanced breast cancer, Small cell lung cancer, Chronic myelomonocytic leukemia

Beyond the preview

Go deeper on Hainan Changan International Pharmaceutical Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hainan Changan International Pharmaceutical Co., Ltd..

Explore the full profile